Tag Archive for: POsitive results

Calliditas Announces Primary Endpoint Successfully Met in Phase 3 NefIgArd Trial Evaluating Nefecon[®] in IgA Nephropathy

/in

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced positive topline results from the global, randomized, double-blind, placebo-controlled Phase 3 clinical trial NefIgArd, which investigated the effect of Nefecon (TARPEYO®/Kinpeygo® (budesonide) delayed release capsules) versus placebo in patients with primary IgA nephropathy (IgAN). The trial met its primary endpoint with Nefecon demonstrating a highly […]

Read more

Poolbeg Pharma: Positive Results from POLB 001 LPS Human Challenge Trial

/in

Strong potential for POLB 001 to be a blockbuster treatment for severe influenza Key Highlights ·      POLB 001 resulted in a highly significant reduction in p38 MAP kinase driven cytokines ·      POLB 001 treatment exhibited a marked reduction in multiple markers of systemic and local inflammation compared with placebo ·    Trial results demonstrate expected utility in severe influenza […]

Read more